annual D&A:
$1.80M+$93.00K(+5.46%)Summary
- As of today (September 16, 2025), APLS annual depreciation & amortization is $1.80 million, with the most recent change of +$93.00 thousand (+5.46%) on December 31, 2024.
- During the last 3 years, APLS annual D&A has risen by +$305.00 thousand (+20.44%).
- APLS annual D&A is now at all-time high.
Performance
APLS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$446.00K$0.00(0.00%)Summary
- As of today (September 16, 2025), APLS quarterly depreciation & amortization is $446.00 thousand, unchanged on June 30, 2025.
- Over the past year, APLS quarterly D&A has dropped by -$3000.00 (-0.67%).
- APLS quarterly D&A is now -8.98% below its all-time high of $490.00 thousand, reached on December 31, 2023.
Performance
APLS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.80M-$3000.00(-0.17%)Summary
- As of today (September 16, 2025), APLS TTM depreciation & amortization is $1.80 million, with the most recent change of -$3000.00 (-0.17%) on June 30, 2025.
- Over the past year, APLS TTM D&A has increased by +$8000.00 (+0.45%).
- APLS TTM D&A is now -2.39% below its all-time high of $1.84 million, reached on September 30, 2024.
Performance
APLS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
APLS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.5% | -0.7% | +0.5% |
| 3 y3 years | +20.4% | +30.4% | +32.8% |
| 5 y5 years | +201.8% | +265.6% | +188.2% |
APLS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.9% | -9.0% | +30.4% | -2.4% | +32.8% |
| 5 y | 5-year | at high | +201.8% | -9.0% | +265.6% | -2.4% | +188.2% |
| alltime | all time | at high | >+9999.0% | -9.0% | +294.0% | -2.4% | +1486.6% |
APLS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $446.00K(0.0%) | $1.80M(-0.2%) |
| Mar 2025 | - | $446.00K(-0.2%) | $1.80M(+0.1%) |
| Dec 2024 | $1.80M(+5.5%) | $447.00K(-2.2%) | $1.80M(-2.3%) |
| Sep 2024 | - | $457.00K(+1.8%) | $1.84M(+2.9%) |
| Jun 2024 | - | $449.00K(+1.1%) | $1.79M(+2.2%) |
| Mar 2024 | - | $444.00K(-9.4%) | $1.75M(+2.6%) |
| Dec 2023 | $1.70M(+14.6%) | $490.00K(+21.0%) | $1.70M(+3.8%) |
| Sep 2023 | - | $405.00K(-1.2%) | $1.64M(+3.0%) |
| Jun 2023 | - | $410.00K(+2.8%) | $1.59M(+4.5%) |
| Mar 2023 | - | $399.00K(-6.8%) | $1.53M(+2.6%) |
| Dec 2022 | $1.49M(-0.3%) | $428.00K(+19.9%) | $1.49M(+3.6%) |
| Sep 2022 | - | $357.00K(+4.4%) | $1.44M(+6.1%) |
| Jun 2022 | - | $342.00K(-5.0%) | $1.35M(-7.3%) |
| Mar 2022 | - | $360.00K(-4.3%) | $1.46M(-2.3%) |
| Dec 2021 | $1.49M | $376.00K(+37.2%) | $1.49M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $274.00K(-38.8%) | $1.40M(-2.9%) |
| Jun 2021 | - | $448.00K(+13.7%) | $1.44M(+29.3%) |
| Mar 2021 | - | $394.00K(+40.7%) | $1.11M(+29.3%) |
| Dec 2020 | $859.00K(+44.3%) | $280.00K(-11.1%) | $859.00K(+8.1%) |
| Sep 2020 | - | $315.00K(+158.2%) | $794.90K(+27.6%) |
| Jun 2020 | - | $122.00K(-14.1%) | $623.20K(-0.2%) |
| Mar 2020 | - | $142.00K(-34.2%) | $624.20K(+4.8%) |
| Dec 2019 | $595.40K(+4903.4%) | $215.90K(+50.7%) | $595.40K(+56.9%) |
| Sep 2019 | - | $143.30K(+16.5%) | $379.50K(+60.7%) |
| Jun 2019 | - | $123.00K(+8.7%) | $236.20K(+108.7%) |
| Mar 2019 | - | $113.20K(-45.7%) | $113.20K(-45.7%) |
| Mar 2018 | - | $208.60K | $208.60K |
| Dec 2017 | $11.90K(+80.3%) | - | - |
| Dec 2014 | $6600.00(+4.8%) | - | - |
| Dec 2013 | $6300.00 | - | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of APLS is $1.80M
What is the all time high annual D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.80M
What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, APLS annual depreciation & amortization has changed by +$93.00K (+5.46%)
What is Apellis Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of APLS is $446.00K
What is the all time high quarterly D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $490.00K
What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, APLS quarterly depreciation & amortization has changed by -$3000.00 (-0.67%)
What is Apellis Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of APLS is $1.80M
What is the all time high TTM D&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $1.84M
What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, APLS TTM depreciation & amortization has changed by +$8000.00 (+0.45%)